|
|
|
|
|
|
Sponsored by: |
National Heart, Lung, and Blood Institute (NHLBI) |
Information provided by: | National Heart, Lung, and Blood Institute (NHLBI) |
ClinicalTrials.gov Identifier: | NCT00379652 |
Hypertension and diabetes are among the most common chronic diseases in the United States. Racial and ethnic minority groups are more at risk for these diseases than the Caucasian population. This study will attempt to identify factors that contribute to racial and ethnic differences in hypertension and diabetes care among minority patients of community health centers (CHCs). This information will be used to design and implement programs to improve quality of care in these communities.
Condition | Intervention |
Hypertension Diabetes Mellitus |
Behavioral: Medical Practice Improvement Behavioral: Patient Education and Support Other: Combination Intervention to Include Medical Practice Improvement and Patient Education and Support |
MedlinePlus related topics: | Diabetes High Blood Pressure |
Study Type: | Interventional |
Study Design: | Health Services Research, Non-Randomized, Open Label, Active Control, Factorial Assignment, Efficacy Study |
Official Title: | Community, Health Center, and Academic Medicine Partnership Project (CHAMPP) |
Estimated Enrollment: | 1204 |
Study Start Date: | October 2007 |
Estimated Study Completion Date: | June 2009 |
Estimated Primary Completion Date: | June 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
A: Active Comparator
Patient-based intervention
|
Behavioral: Patient Education and Support
The details for the patient education and support intervention will be decided at a later date.
|
B: Active Comparator
Health center-based intervention
|
Behavioral: Medical Practice Improvement
The details for the medical practice improvement intervention will be decided at a later date.
|
C: Active Comparator
Combination of patient and health center-based intervention
|
Other: Combination Intervention to Include Medical Practice Improvement and Patient Education and Support
The details for this combination intervention will be decided at a later date.
|
D: No Intervention
Control group
|
Hypertension and diabetes are the primary contributors to today's high rates of heart disease and stroke, which are the first and third leading causes of death in the United States, respectively. African Americans and Hispanics have a higher risk of developing hypertension and diabetes than do Caucasians. They are also less likely to know that they have high blood pressure, are more prone to organ damage, and are more likely to die as a result of these chronic conditions. A significant number of African Americans and Hispanics are uninsured and receive care through publicly supported CHCs. It is important to identify factors that contribute to healthcare differences among the lower income, uninsured, and minority populations that are typically served by CHCs. In this study, a collaborative partnership will be developed between CHCs, health service research organizations, and academic researchers. The goal of the study is to examine the barriers that minority CHC patients face in receiving appropriate hypertension and diabetes care.
This study will develop a collaborative partnership between various health organizations and seven CHCs located in Boston neighborhoods that have a large percentage of African American and Hispanic residents. Researchers will conduct focus groups with CHC patients who are receiving care for hypertension or diabetes. CHC staff members will be interviewed to collect information regarding the relationship between CHC organizational structure and disparities in heart disease risk factors among minority patients with hypertension or diabetes. Researchers will then develop, implement, and evaluate a patient- and CHC-focused intervention aimed at reducing the cardiovascular risks of minority patients at four CHCs in Boston.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Contact: Thomas Keegan, PhD | 617-432-4335 | keegan@hcp.med.harvard.edu |
United States, Massachusetts | |||||
Harvard Medical School | Recruiting | ||||
Boston, Massachusetts, United States, 02115 | |||||
Sub-Investigator: John Z. Ayanian, MD | |||||
Sub-Investigator: Bruce E. Landon, MD, MBA | |||||
Sub-Investigator: James O'Malley, PhD | |||||
Principal Investigator: LeRoi S. Hicks, MD, MPH | |||||
Center for Community Health Education, Research, and Service | Recruiting | ||||
Boston, Massachusetts, United States, 02118 | |||||
Principal Investigator: Elmer Freeman, MSW | |||||
Sub-Investigator: Beverley Russell, MSN, PhD |
Principal Investigator: | LeRoi S. Hicks, MD, MPH | Harvard University |
Study Director: | Thomas Keegan, PhD | Harvard University |
Responsible Party: | Harvard Medical School ( LeRoi S. Hicks, MD, MPH ) |
Study ID Numbers: | 410, 1 R21 HL083859-01 |
First Received: | September 20, 2006 |
Last Updated: | July 28, 2008 |
ClinicalTrials.gov Identifier: | NCT00379652 |
Health Authority: | United States: Federal Government |
|
|
|
|